eicosapentaenoic acid ethyl ester has been researched along with vericiguat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Agarwala, A; Al Rifai, M; Gulati, M; Jia, X; Liu, J; Virani, SS | 1 |
1 review(s) available for eicosapentaenoic acid ethyl ester and vericiguat
Article | Year |
---|---|
Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Child; Cholesterol, LDL; Denervation; Eicosapentaenoic Acid; Electronic Nicotine Delivery Systems; Female; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Hyperlipoproteinemia Type II; Hypertension; Kidney; Male; Middle Aged; Pyrimidines; Randomized Controlled Trials as Topic; Smoking Cessation; United States; Young Adult | 2020 |